In the wake of the coronavirus pandemic, the IPO market may never look the same. The swift shift to virtual roadshows, for example, has demonstrated efficiencies that are likely to make digital alternatives stick even after regular business travel resumes. But beyond the operational changes behind preparing a company to go public, the market has seen growing interest in alternatives to the IPO itself.
Posts by Jeff Bernstein
Jeff Bernstein is a managing director at ICR who applies his over 30 years of experience to guide founders, management teams, and Board’s of Directors through critical capital events – helping them to optimize decision making and preserving optionality throughout the process.
Clinical trial data disclosure can be tricky.
Download our checklist of 10 disclosure guidelines to minimize risk and maximize the impact of good news.